Description
RADIOPHARMACEUTICALS
First action · last action
2019-10-01 · 2024-09-04
Transactions
9
First transaction's obligation
$142,994
Base + all options value (sum of deltas)
$1,065,381
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-01+$142,994= $142,994
- Mod P000012020-10-01+$142,994= $285,989
- Mod P000022021-03-31-$53,271= $232,718
- Mod P000032021-10-01+$142,994= $375,712
- Mod P000042022-10-01+$142,994= $518,706
- Mod P000052022-11-16-$47,201= $471,505
- Mod P000062023-10-01+$142,994= $614,499
- Mod P000072024-09-04-$63,669= $550,830
- Mod P000082024-09-04-$57,427= $493,403
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-01 | +$142,994 | $142,994 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2020-10-01 | +$142,994 | $285,989 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2021-03-31 | −$53,271 | $232,718 | RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2021-10-01 | +$142,994 | $375,712 | RADIOPHARMACEUTICALS |
| Mod P00004· EXERCISE AN OPTION | 2022-10-01 | +$142,994 | $518,706 | RADIOPHARMACEUTICALS |
| Mod P00005· FUNDING ONLY ACTION | 2022-11-16 | −$47,201 | $471,505 | RADIOPHARMACEUTICALS |
| Mod P00006· EXERCISE AN OPTION | 2023-10-01 | +$142,994 | $614,499 | RADIOPHARMACEUTICALS |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-04 | −$63,669 | $550,830 | RADIOPHARMACEUTICALS |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-09-04 | −$57,427 | $493,403 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RQAKL78AXMT5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226P0481 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $3,356,110 | FY2026 |
| 36C24426P0225 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $148,383 | FY2026 |
| 36C24226D0037 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24226N0381 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $959,170 | FY2026 |
| 36C24425N0451 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $180,327 | FY2025 |
| 36C24225N0376 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $51,681 | FY2025 |
Other recipients under 6505 from 244-NETWORK CONTRACT OFFICE 4 (36C244) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24426D0097 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $0 | FY2026 |
| 36C24426N0938 | CARDINAL HEALTH 414, LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $650,641 | FY2026 |
| 36C24426N0948 | ERA HEALTH LLC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $29,590 | FY2026 |
| 36C24426P0339 | NUCLEAR DIAGNOSTIC PRODUCTS OF PHILADELPHIA, INC | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $126,204 | FY2026 |
| 36C24426N0663 | LUMINEX CORP | 244-NETWORK CONTRACT OFFICE 4 (36C244) | $121,316 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24420P0050_3600_-NONE-_-NONE- · retrieved 2026-09-26.